NEXXEN holder plans sale of 80,000 shares

Accepted by SEC EDGAR 07/14/2026 - 08:16 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

NEXXEN International Ltd. security holder Carmi Yaniv submitted a Form 144 notice for a proposed sale of 80,000 ordinary shares of NEXN through Oppenheimer & Co. Inc., with an aggregate market value of $772,400.00, to be sold on or after July 13, 2026 on Nasdaq.

The notice also lists 56,284,083 ordinary shares outstanding. The shares to be sold were acquired on October 6, 2022 upon vesting of RSUs, totaling 82,500 shares, for which no cash consideration was paid. During the past three months, 28,270 ordinary shares were sold for $280,678.70 on July 13, 2026.

Key Figures

Shares to be sold: 80,000 shares Aggregate market value of proposed sale: $772,400.00 Shares outstanding: 56,284,083 shares +3 more

6 metrics

Shares to be sold 80,000 shares Ordinary shares in proposed Form 144 sale via Oppenheimer & Co. Inc.

Aggregate market value of proposed sale $772,400.00 Stated aggregate market value of the 80,000 ordinary shares to be sold

Shares outstanding 56,284,083 shares Ordinary shares outstanding referenced in the Form 144 notice

Shares acquired via RSU vesting 82,500 shares Ordinary shares issued on 10/06/2022 upon vesting of RSUs, no consideration

Recent shares sold 28,270 shares Ordinary shares sold on 07/13/2026 during the past three months

Value of recent sale $280,678.70 Aggregate sale price for 28,270 ordinary shares sold on 07/13/2026

Key Terms

RSUs, Ordinary Shares, No consideration, Nasdaq

4 terms

RSUs financial

"Shares issued upon vesting of RSUs"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

Ordinary Shares financial

"Ordinary Shares | Oppenheimer & Co. Inc."

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

No consideration financial

"No consideration, shares issued upon vesting of RSUs"

Nasdaq market

"07/13/2026 | Nasdaq"

The Nasdaq is a stock exchange where many companies' shares are bought and sold, functioning much like a marketplace for investments. It matters to investors because it provides a platform to buy and sell ownership stakes in companies, helping them track the value of those companies and make informed decisions. As one of the largest and most technology-focused markets, it also reflects trends and developments in the business world.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What share sale did NEXXEN International (NEXN) disclose in this Form 144 notice?

The notice reports a proposed sale of 80,000 ordinary shares of NEXN by security holder Carmi Yaniv through Oppenheimer & Co. Inc., with an aggregate market value of $772,400.00, to be executed on or after July 13, 2026 on Nasdaq.

How many NEXN shares are proposed for sale and what is their stated value?

The Form 144 notice covers a proposed sale of 80,000 ordinary shares of NEXN, with a stated aggregate market value of $772,400.00. These shares are planned to be sold through Oppenheimer & Co. Inc. on or after July 13, 2026.

How and when were the NEXXEN (NEXN) shares being sold acquired?

The ordinary shares being sold were acquired on October 6, 2022 upon vesting of RSUs. The notice states that 82,500 shares were issued to the holder with no consideration, meaning no cash payment was made for these shares at acquisition.

What recent NEXN share sales does the Form 144 notice describe for the past 3 months?

The notice lists a recent sale of 28,270 ordinary shares of NEXN on July 13, 2026 with an aggregate sale price of $280,678.70. This transaction is identified as securities sold during the past three months by the same security holder.

How many NEXXEN (NEXN) ordinary shares are outstanding according to this notice?

The Form 144 notice cites 56,284,083 ordinary shares of NEXN as outstanding. This figure provides context for the holder’s proposed sale of 80,000 shares, indicating the broader equity base relative to the contemplated transaction size.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001980184
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Nexxen International Ltd.
SEC File Number	001-40504
Address of Issuer	82 YIGAL ALON STREET 13TH FLOOR TEL AVIV ISRAEL 00000
Phone	972-3-545-3900
Name of Person for Whose Account the Securities are To Be Sold	Carmi Yaniv
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary Shares	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	80000	772400.00	56284083	07/13/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary Shares	10/06/2022	Shares issued upon vesting of RSUs	NEXXEN INTERNATIONAL LTD.			82500	10/06/2022	No consideration, shares issued upon vesting of RSUs

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Carmi Yaniv 82 YIGAL ALON STREET TEL AVIV L3 00000	Ordinary Shares	07/13/2026	28270	280678.70

144: Remarks and Signature

Remarks	The securities are being sold pursuant to a Rule 10b51 trading plan adopted on 05/16/2025
Date of Notice	07/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Yaniv Carmi By: /s/ Netta Cohen Title: Authorized Signatory, Oppenheimer Israel (pursuant to delegation)
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)